We are live on ! Find out more
MAA

Mraz Amerine & Associates Portfolio holdings

AUM $697M
1-Year Est. Return 19.37%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+19.37%
3 Year Est. Return
+69.82%
5 Year Est. Return
+110.04%
10 Year Est. Return
+414.75%
AUM
$208M
AUM Growth
+$11.3M
Cap. Flow
+$1.78M
Cap. Flow %
0.85%
Top 10 Hldgs %
52.81%
Holding
137
New
10
Increased
32
Reduced
27
Closed
6

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.14M
2
ABBV icon
AbbVie
ABBV
+$988K
3
AON icon
Aon
AON
+$656K
4
OFG icon
OFG Bancorp
OFG
+$567K
5
BIIB icon
Biogen
BIIB
+$232K

Sector Composition

Rank Sector Weight
1 Financials 54.26%
2 Energy 16.72%
3 Communication Services 5.41%
4 Technology 3.92%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBFO
126
DELISTED
United Security Bancshares
UBFO
$67K 0.03%
18,266
IO
127
DELISTED
ION Geophysical Corporation
IO
$66K 0.03%
847
CXPO
128
DELISTED
Crimson Exploration Inc. New Common Stock
CXPO
$36K 0.02%
12,000
TLAB
129
DELISTED
TELLABS INC
TLAB
$28K 0.01%
12,500
ALO
130
DELISTED
Alio Gold Inc
ALO
$17K 0.01%
+1,000
New +$20.3K
LGL.WS
131
DELISTED
LGL GROUP INC WT EXP 08/06/2018
LGL.WS
$1K ﹤0.01%
+15,000
New +$1.49K
AON icon
132
Aon
AON
$76B
-10,199
Closed -$656K
BIIB icon
133
Biogen
BIIB
$30.7B
-1,080
Closed -$232K
GSK icon
134
GSK
GSK
$106B
-18,195
Closed -$1.14M
OFG icon
135
OFG Bancorp
OFG
$2.21B
-31,330
Closed -$567K
T icon
136
AT&T
T
$163B
-7,493
Closed -$200K
MTSN
137
DELISTED
MATTSON TECHNOLOGY INC
MTSN
-12,500
Closed -$27K

Similar funds

Mraz Amerine & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Mraz Amerine & Associates held 137 positions worth $208M, up 5.7% from $197M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Mraz Amerine & Associates's Q3 2013 filing shows 10 new, 32 increased, 27 reduced and 6 closed positions. Its largest new stake was AXIALL CORP COM STK (DE): 12,400 shares worth $469K. The largest sale was GSK, an estimated $1.14M.

By sector, the portfolio is most concentrated in Financials at 54% of assets, down from 55% a quarter earlier, followed by Energy and Communication Services.

  • Mraz Amerine & Associates's largest Q3 2013 buy was AXIALL CORP COM STK (DE): 12,400 shares worth $469K.
  • Mraz Amerine & Associates added most to Markel Group in Q3 2013, an estimated $835K increase.
  • Mraz Amerine & Associates's biggest Q3 2013 reduction was AbbVie, cutting an estimated $988K.
  • Mraz Amerine & Associates fully exited GSK in Q3 2013, selling an estimated $1.14M.
  • Mraz Amerine & Associates's ten largest holdings make up 53% of its $208M portfolio in Q3 2013.
  • Mraz Amerine & Associates opened 10 new positions and closed 6 in Q3 2013.
  • Mraz Amerine & Associates's portfolio value rose 5.7% quarter-over-quarter to $208M.

Based on Mraz Amerine & Associates's 13F filing for Q3 2013, filed 18 Oct 2013.